Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$4.03 - $8.13 $533,434 - $1.08 Million
132,366 Added 353.49%
169,812 $1.38 Million
Q4 2023

Feb 14, 2024

SELL
$3.56 - $4.65 $12,755 - $16,660
-3,583 Reduced 8.73%
37,446 $149,000
Q3 2023

Nov 14, 2023

BUY
$4.02 - $5.81 $164,936 - $238,378
41,029 New
41,029 $169,000
Q1 2023

May 16, 2023

BUY
$3.22 - $4.72 $122,884 - $180,129
38,163 New
38,163 $131,000
Q2 2022

Aug 15, 2022

BUY
$5.13 - $9.2 $116,958 - $209,750
22,799 New
22,799 $128,000
Q1 2022

May 16, 2022

SELL
$8.64 - $11.71 $112,380 - $152,311
-13,007 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$10.95 - $16.07 $32,171 - $47,213
2,938 Added 29.18%
13,007 $145,000
Q3 2021

Nov 15, 2021

BUY
$12.95 - $18.24 $130,393 - $183,658
10,069 New
10,069 $130,000
Q2 2021

Aug 11, 2021

SELL
$15.83 - $17.84 $342,941 - $386,485
-21,664 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$15.92 - $20.3 $85,697 - $109,274
5,383 Added 33.06%
21,664 $372,000
Q3 2020

Nov 16, 2020

SELL
$13.97 - $21.16 $285,239 - $432,044
-20,418 Reduced 55.64%
16,281 $311,000
Q2 2020

Aug 14, 2020

BUY
$10.39 - $16.07 $125,968 - $194,832
12,124 Added 49.33%
36,699 $503,000
Q1 2020

May 15, 2020

SELL
$8.89 - $24.94 $177,924 - $499,149
-20,014 Reduced 44.89%
24,575 $261,000
Q4 2019

Feb 14, 2020

BUY
$8.33 - $19.95 $80,017 - $191,639
9,606 Added 27.46%
44,589 $832,000
Q3 2019

Nov 14, 2019

SELL
$6.86 - $10.46 $209,593 - $319,584
-30,553 Reduced 46.62%
34,983 $366,000
Q2 2019

Aug 16, 2019

BUY
$6.99 - $11.27 $10,792 - $17,400
1,544 Added 2.41%
65,536 $497,000
Q2 2019

Aug 14, 2019

BUY
$6.99 - $11.27 $120,961 - $195,027
17,305 Added 37.07%
63,992 $485,000
Q1 2019

May 15, 2019

BUY
$5.05 - $11.62 $147,353 - $339,059
29,179 Added 166.66%
46,687 $514,000
Q4 2018

Feb 14, 2019

BUY
$3.22 - $6.27 $56,375 - $109,775
17,508 New
17,508 $89,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $114M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.